Companies: 10,795·Total market cap: $144.5T
Autolus Therapeutics plc

Autolus Therapeutics plc

AUTLNASDAQHealthcare● Active
$1.53
$-0.13(-7.83%)
Market Cap$407199199
P/E Ratio
52W High$2.7
52W Low$1.175

Autolus Therapeutics plc (AUTL) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

autl · stock forecast · 14 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 14 Wall Street analysts in the past 3 months

SellBuy

Buy

14 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
11
Hold
3
Sell
0
Strong Sell
0
Total: 14 · Buy rate: 78.6%

12-Month Price Target

High

$11.00

Consensus

$8.87

+479.7% upside

Low

$7.60

Median: $8 · Last Close: $1.53

The Autolus Therapeutics plc (AUTL) analyst consensus is Buy, based on ratings from 14 Wall Street analysts over the past 3 months. The average 12-month AUTL price target is $8.87, representing +479.7% upside from the current price of $1.53.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $9 (479.7%)

Consensus Target

$8.87

479.7% upside

High Target

$11

619.0%

Low Target

$7.6

396.7%

Current Price

$1.53

as of today

Based on analyst price targets, the AUTL stock price prediction for the next 12 months ranges from $7.6 to $11. The consensus AUTL price forecast of $8.87 implies 479.7% upside from the current price of $1.53.

Short-Term Price Prediction

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$1.530.31%

1-day model range: $1.52–$1.55. Peak: $1.55 (+0.31%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$1-29.5%
2028$1-40.9%
2029$1-46.2%
2030$1-48.8%
2031-50.2%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BEARISH

Based on 14 technical indicators

14%7%79%
2Buy
1Neutral
11Sell
RSI (14)45.3Neutral
MACDBULLISH

Refreshes daily from EOD close

Moving Averages · AUTL · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$1.68SELL
MA 10$1.71SELL
MA 20$1.67SELL
MA 50$1.55SELL
MA 100$1.52BUY
MA 200$1.53SELL
Current $AUTL · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$1.64SELL
EMA 10$1.67SELL
EMA 20$1.66SELL
EMA 50$1.60SELL
EMA 100$1.58SELL
EMA 200$1.66SELL
Current $AUTL · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
HC Wainwright & Co.2026-05-14
Maintains
BuyBuy
Needham2026-04-09
Maintains
BuyBuy
Mizuho2026-03-31
Maintains
OutperformOutperform
Needham2026-03-27
Maintains
BuyBuy
Needham2026-01-12
Maintains
BuyBuy
Needham2025-12-29
Maintains
BuyBuy
Needham2025-12-12
Maintains
BuyBuy
Needham2025-11-03
Maintains
BuyBuy
Needham2025-10-20
Maintains
BuyBuy
Wells Fargo2025-08-13
Maintains
OverweightOverweight

Wall Street analysts have recently issued updated ratings on Autolus Therapeutics plc (AUTL) stock. Of the recent 64 rating actions, 2 were upgrades and 4 were downgrades. 14 analysts currently cover AUTL.

Analyst Recommendation Trends

Buy ratings11
Hold ratings00
Sell ratings00

AUTL analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$130M

↓ 58.3% YoY

Revenue Next Year

$200M

↑ 54.5% YoY

EPS This Year

$-0.89

EPS Next Year

$-0.64

↓ 28.7% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast AUTL EPS of $-0.89 for the current fiscal year, based on estimates from 7 analysts. The AUTL revenue forecast is $130M for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The AUTL stock forecast is supported by two independent data sources: analyst consensus ratings from 14 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus AUTL price target is $8.87 (+479.7% upside), with an analyst consensus of Buy.

The AUTL short-term stock prediction for tomorrow is $1.53 (+0.31%). The AUTL stock price prediction for 2027 estimates an average of $1. The AUTL stock prediction for 2030 projects a range of $1–$1.

Autolus Therapeutics plc trades on NASDAQ under the ticker AUTL. The AUTL stock outlook for 2027 is broadly positive, supported by a Buy consensus among 79% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

AUTL forecast · 8 questions

According to 14 Wall Street analysts, the average 12-month AUTL price target is $8.87, with a high forecast of $11.00 and a low of $7.60. The median price target is shown in the chart above when available. This implies +479.7% potential upside from the current price of $1.53.

AUTL price targetWhat is AUTL price targetAUTL analyst price targetAUTL 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.